Netherlands· NL-81f83f79709e

Konakion mixed micelles, 10 mg/ml oplossing voor injectie en oraal gebruik

A phytomenadione product containing fytomenadion, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC B02BA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fytomenadionAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Phytomenadione is registered in 15 of 19 countries.

Countries holding a registration under ATC B02BA01 (phytomenadione), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search phytomenadione products by name

Phytomenadione · ATC B02BA01

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FYTOMENADION
Manufacturer: CHEPLAPHARM Arzneimittel GmbH
Country: Netherlands (NL)
ATC code: B02BA01
ATC class: Phytomenadione
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
03808

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

188 interactions on record for phytomenadione.

Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check phytomenadione against other medicines How interaction checks work

Phytomenadione · interactions on record

188 records

6 moderate
2 minor
180 info

Most severe, free to view

DicoumarolB01AA01moderate
WarfarinB01AA03moderate
ColestyramineC10AC01moderate
ColestipolC10AC02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Phytomenadione in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phytomenadione products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Austria · Konakion
Belgium · Konakion, Konakion Paediatric
Cyprus · Kanavit
Czechia · Kanavit
Germany · Ka-Vit Tropfen, Konakion
Denmark · Konakion Novum, Menadion Scanpharm
Spain · Konakion, Konakion Pediátrico
Finland · Konakion Novum
France · Vitamine K1 Cheplapharm, Vitamine K1 Nourrissons Cheplapharm
United Kingdom (Northern Ireland) · Konakion Mm Ampoules, Konakion Mm Paediatric
Croatia · Konakion Mm
Hungary · Konakion
Ireland · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
Italy · Konakion, Konakion Prima Infanzia
Malta · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
Norway · Konakion
Poland · Phytomenadione Bb Pharma, Vitacon
Portugal · Kanakion Mm, Kanakion Mm Pediátrico
Romania · Fitomenadion Terapia
Sweden · Konakion
Slovakia · Kanavit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f765cc51-07bc-4dc0-984a-28c8ca043f2f
GET /v1/drugs/f765cc51-07bc-4dc0-984a-28c8ca043f2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03808_smpc.pdf",
  "strength": null,
  "atc_label": "Phytomenadione",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03808",
  "excipients": [
    "GLYCOCHOLZUUR",
    "LECITHINE (E 322)",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FYTOMENADION"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03808.pdf",
  "authorised_at": "1990/03/14",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "03808",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about phytomenadione.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console